CTRI/2021/12/038695尚未招募未知
Multicenter Observational Study on Practice of Ventilation in Brain Injured Patients: VENTIBRAIN - VENTIBRAI
niversit degli Studi di MilanoBicocca0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Adult patients admitted to the ICU with a diagnosis of
- •â?¦ traumatic brain injury or
- •â?¦ cerebrovascular diseases (intracranial hemorrhage, subarachnoid hemorrhage, ischemic stroke)
- •Patients requiring intubation and mechanical ventilation in the ICU
- •Informed consent
排除标准
- •Age < 18 years
- •Pregnant patients
- •Patients not intubated or not mechanically ventilated or receiving only nonâ??invasive ventilation (i.e., patient never received invasive ventilation during the present admission) • Patients under invasive mechanical ventilation before the inclusion
研究者
相似试验
已完成
不适用
Multicenter study for training and evaluation of various computer-assisted detection (CAD) software (2nd period)cerebral aneurysm lung noduleJPRN-UMIN000017981The University of Tokyo Hospital3,000
已完成
不适用
Multicenter Study for training and evaluation of various computer-assisted detection (CAD) software (1st period)cerebral aneurysm lung noduleJPRN-UMIN000015240The University of Tokyo Hospital2,000
进行中（未招募）
不适用
A Randomized, Double-blind, Multicenter Study of Visilizumab versus Placebo in Subjects with Intravenous Steroid-refractory Ulcerative Colitis Previously Responsive in a Visilizumab Study - RESTORE™ RIntravenous steroid-refractory ulcerative colitis (IVSR-UC)MedDRA version: 9.0Level: LLTClassification code 10045365EUCTR2005-003481-42-GRPDL BioPharma, Inc.80
进行中（未招募）
1 期
A Randomized, Double-blind, Multicenter Study of Visilizumab versus Placebo in Subjects with Intravenous Steroid-refractory Ulcerative Colitis Previously Responsive in a Visilizumab StudyIntravenous steroid-refractory ulcerative colitis (IVSR-UC)EUCTR2005-003481-42-IEPDL BioPharma, Inc80
进行中（未招募）
不适用
A Randomized, Double-blind, Multicenter Study of Visilizumab versus Placebo in Subjects with Intravenous Steroid-refractory Ulcerative Colitis Previously Responsive in a Visilizumab Study - RESTORE™ RIntravenous steroid-refractory ulcerative colitis (IVSR-UC)MedDRA version: 9.0Level: LLTClassification code 10045365EUCTR2005-003481-42-HUPDL BioPharma, Inc.80